MRNA Vaccine Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global mRNA vaccine market is expected to grow at a significant CAGR during the forecast period (2021-2027). The mRNA is a single-stranded molecule that carries genetic code from DNA in a cell’s nucleus to ribosome that provides a basis for protein synthesis within the cells. The mRNA vaccines and therapeutics include non-replicating mRNA, in-vivo self-replicating mRNA, and in-vitro dendritic cell non-replicating mRNA vaccine that comprise the desirable immunological properties. Enhanced immunogenicity, rapid development, higher potency, efficacy against pathogens, relatively economical and safer over the conventional vaccines are the key benefits that mRNA vaccines offer. The rising adoption of the mRNA vaccines owing to its offered benefits is a major factor contributing towards the growth of the global mRNA vaccine market.
To Request a Sample of our Report on mRNA Vaccine Market: https://www.omrglobal.com/request-sample/mrna-vaccine-market
The mRNA vaccine finds their use
in the treatment of infectious diseases, immuno-oncology, rare diseases, and
CVD. The rising prevalence of chronic diseases such as diabetes, tuberculosis,
cancer and CVD, among others along with the rising adoption of the mRNA
vaccines owing to their high efficacy is promoting the mRNA vaccine
manufacturers to enter into agreement with prominent vaccine developers to
expedite the manufacturing process. In 2019, among European countries, the
prevalence of diabetes was highest in Germany with 15.3% aged populations
living with diabetes. Moreover, rising funding in the R&D of mRNA vaccines
is further anticipated to boost the market growth. For instance, in March 2020,
Janssen Global Services, LLC (Johnson & Johnson) had entered into
partnership with the Biomedical Advanced Research and Development Authority of
the US Department of Health and Human Services to fund over $1 billion in the
R&D of COVID-19 vaccine and antiviral treatment. However, strict regulatory
criteria, lack of skilled workforce and storage related issues may restrain the
growth of the global mRNA vaccine market.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
AstraZeneca plc, Pfizer Inc., and Sanofi SA, among others.
(Get 15% Discount on Buying this Report)
A
full Report of mRNA Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/mrna-vaccine-market
Global mRNA Vaccine Market Report by Segment
By Type
• Bioengineered
Vaccine
• Gene
Therapy
• Cell
Therapy
• Monoclonal
Anti-Body Based Treatment
• Others
By Application
• Infectious
Disease Vaccines
• Cancer
Vaccines
Global mRNA Vaccine Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment